Procter & Gamble (PG)
(Real Time Quote from BATS)
$145.98 USD
-0.54 (-0.37%)
Updated Jun 5, 2023 01:48 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
PG 145.98 -0.54(-0.37%)
Will PG be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for PG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PG
Boston Beer (SAM) Relies on Growth Strategic Amid Cost Woes
Molson Coors (TAP) Gains 13.8% in 3 Months Amid Inflation Woes
PG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
Other News for PG
Changing dishwashing habits can help save more than 3.5 million tonnes of CO2 in Europe
How To Build Wealth: Buy Low And Sell High Consistently
Dividend Income Summary: Lanny's May 2023 Summary
Trian Fund co-founder Ed Garden set to exit firm, to leave Janus Henderson board
Cannabis company Acreage names former Procter & Gamble exec as CEO